Not yet recruitingPhase 2NCT05303727

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Studying Neuroblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator
Yang Li
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Intervention
Anti Thymocyte Globulin(drug)
Enrollment
64 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05303727 on ClinicalTrials.gov

Other trials for Neuroblastoma

Additional recruiting or active studies for the same condition.

See all trials for Neuroblastoma →

← Back to all trials